Literature DB >> 32115621

Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma.

Marta Melis1,2, Tuo Zhang3,4, Theresa Scognamiglio5, Lorraine J Gudas1,2,6.   

Abstract

Oral squamous cell carcinomas (OSCCs) are the most common cancers of the oral cavity, but the molecular mechanisms driving OSCC carcinogenesis remain unclear. Our group previously established a murine OSCC model based on a 10-week carcinogen [4-nitroquinoline 1-oxide (4-NQO)] treatment. Here we used K14CreERTAM;Rosa26LacZ mice to perform lineage tracing to delineate the mutational profiles in clonal cell populations resulting from single, long-lived epithelial stem cells, here called LacZ+ stem cell clones (LSCCs). Using laser-capture microdissection, we examined mutational changes in LSCCs immediately after the 10-week 4-NQO treatment and >17 weeks after 4-NQO treatment. We found a 1.8-fold ±0.4 (P = 0.009) increase in single-nucleotide variants and insertions/deletions (indels) in tumor compared with pre-neoplastic LSCCs. The percentages of indels and of loss of heterozygosity events were 1.3-fold±0.3 (P = 0.02) and 2.2-fold±0.7 (P = 0.08) higher in pre-neoplastic compared with tumor LSCCs. Mutations in cell adhesion- and development-associated genes occurred in 83% of the tumor LSCCs. Frequently mutated genes in tumor LSCCs were involved in planar cell polarity (Celsr1, Fat4) or development (Notch1). Chromosomal amplifications in 50% of the tumor LSCCs occurred in epidermal growth factor receptor, phosphoinositide 3-kinase and cell adhesion pathways. All pre-neoplastic and tumor LSCCs were characterized by key smoking-associated changes also observed in human OSCC, C>A and G>T. DeconstructSigs analysis identified smoking and head and neck cancer as the most frequent mutational signatures in pre-neoplastic and tumor LSCCs. Thus, this model recapitulates a smoking-associated mutational profile also observed in humans and illustrates the role of LSCCs in early carcinogenesis and OSCCs.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32115621      PMCID: PMC7896111          DOI: 10.1093/carcin/bgaa019

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  52 in total

1.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.

Authors:  Daniel C Koboldt; Qunyuan Zhang; David E Larson; Dong Shen; Michael D McLellan; Ling Lin; Christopher A Miller; Elaine R Mardis; Li Ding; Richard K Wilson
Journal:  Genome Res       Date:  2012-02-02       Impact factor: 9.043

2.  Carcinogenesis of the Oral Cavity: Environmental Causes and Potential Prevention by Black Raspberry.

Authors:  Karam El-Bayoumy; Kun-Ming Chen; Shang-Min Zhang; Yuan-Wan Sun; Shantu Amin; Gary Stoner; Joseph B Guttenplan
Journal:  Chem Res Toxicol       Date:  2016-12-02       Impact factor: 3.739

3.  Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.

Authors:  Rebecca Rock; Sabrina Schrauth; Manfred Gessler
Journal:  Dev Dyn       Date:  2005-11       Impact factor: 3.780

Review 4.  4-nitroquinoline-1-oxide induced experimental oral carcinogenesis.

Authors:  Deepak Kanojia; Milind M Vaidya
Journal:  Oral Oncol       Date:  2006-01-30       Impact factor: 5.337

5.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

6.  Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers.

Authors:  Curtis R Pickering; Jiexin Zhang; David M Neskey; Mei Zhao; Samar A Jasser; Jiping Wang; Alexandra Ward; C Jillian Tsai; Marcus V Ortega Alves; Jane H Zhou; Jennifer Drummond; Adel K El-Naggar; Richard Gibbs; John N Weinstein; David A Wheeler; Jing Wang; Mitchell J Frederick; Jeffrey N Myers
Journal:  Clin Cancer Res       Date:  2014-05-29       Impact factor: 12.531

7.  Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.

Authors:  Klaus H Metzeler; Tobias Herold; Maja Rothenberg-Thurley; Susanne Amler; Maria C Sauerland; Dennis Görlich; Stephanie Schneider; Nikola P Konstandin; Annika Dufour; Kathrin Bräundl; Bianka Ksienzyk; Evelyn Zellmeier; Luise Hartmann; Philipp A Greif; Michael Fiegl; Marion Subklewe; Stefan K Bohlander; Utz Krug; Andreas Faldum; Wolfgang E Berdel; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann; Jan Braess; Karsten Spiekermann
Journal:  Blood       Date:  2016-06-10       Impact factor: 22.113

8.  DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution.

Authors:  Rachel Rosenthal; Nicholas McGranahan; Javier Herrero; Barry S Taylor; Charles Swanton
Journal:  Genome Biol       Date:  2016-02-22       Impact factor: 13.583

9.  Low FAT4 expression is associated with a poor prognosis in gastric cancer patients.

Authors:  Xiaoting Jiang; Zhengchuang Liu; Yingjie Xia; Jungang Luo; Ji Xu; Xujun He; Houquan Tao
Journal:  Oncotarget       Date:  2017-12-26

10.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

View more
  4 in total

1.  EZH2 knockout in oral cavity basal epithelia causes more invasive squamous cell carcinomas.

Authors:  Jorge Baquero; Xiao-Han Tang; Theresa Scognamiglio; Lorraine J Gudas
Journal:  Carcinogenesis       Date:  2021-12-31       Impact factor: 4.741

2.  CELSR1 Acts as an Oncogene Regulated by miR-199a-5p in Glioma.

Authors:  Guang Wang; Yong Li; Dongxia Zhang; Songtao Zhao; Qiong Zhang; Chao Luo; Xiaochuan Sun; Bingqian Zhang
Journal:  Cancer Manag Res       Date:  2020-09-23       Impact factor: 3.989

3.  A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinoma.

Authors:  Erdem Bangi; Peter Smibert; Andrew V Uzilov; Alexander G Teague; Sindhura Gopinath; Yevgeniy Antipin; Rong Chen; Chana Hecht; Nelson Gruszczynski; Wesley J Yon; Denis Malyshev; Denise Laspina; Isaiah Selkridge; Huan Wang; Jorge Gomez; John Mascarenhas; Aye S Moe; Chun Yee Lau; Patricia Taik; Chetanya Pandya; Max Sung; Sara Kim; Kendra Yum; Robert Sebra; Michael Donovan; Krzysztof Misiukiewicz; Celina Ang; Eric E Schadt; Marshall R Posner; Ross L Cagan
Journal:  iScience       Date:  2021-02-20

Review 4.  Obscurin: A multitasking giant in the fight against cancer.

Authors:  Talia Guardia; Matthew Eason; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-05-18       Impact factor: 11.414

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.